Climb Bio, Inc. (CLYM)
NASDAQ: CLYM · Real-Time Price · USD
7.15
-0.24 (-3.25%)
Mar 6, 2026, 12:22 PM EST - Market open
Climb Bio Stock Forecast
Stock Price Forecast
The 6 analysts with 12-month price forecasts for Climb Bio stock have an average target of 13, with a low estimate of 8.00 and a high estimate of 23. The average target predicts an increase of 81.82% from the current stock price of 7.15.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Climb Bio stock from 7 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '25 | Nov '25 | Dec '25 | Jan '26 | Feb '26 | Mar '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 3 | 3 | 3 | 3 | 4 | 5 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 5 | 6 | 7 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Wedbush | Wedbush | Buy Maintains $12 → $14 | Buy | Maintains | $12 → $14 | +95.80% | Mar 6, 2026 |
| Baird | Baird | Buy Maintains $9 → $12 | Buy | Maintains | $9 → $12 | +67.83% | Mar 6, 2026 |
| Wedbush | Wedbush | Buy Initiates $12 | Buy | Initiates | $12 | +67.83% | Mar 5, 2026 |
| Piper Sandler | Piper Sandler | Buy Initiates $23 | Buy | Initiates | $23 | +221.68% | Feb 13, 2026 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Maintains $9 → $11 | Strong Buy | Maintains | $9 → $11 | +53.85% | Dec 18, 2025 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-0.90
from -0.88
EPS Next Year
-1.14
from -0.90
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | n/a | n/a | |||
| Avg | n/a | n/a | |||
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | -0.76 | -1.10 | |||
| Avg | -0.90 | -1.14 | |||
| Low | -1.06 | -1.25 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | - | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.